NEW YORK (GenomeWeb News) – Abraxis BioScience has awarded the John Wayne Cancer Institute at Saint John's Health Center in Santa Monica, Calif., a $1 million grant to search for genes and proteins that can serve as biomarkers for solid-tumor cancers.

The funding was awarded to John Wayne's Department of Molecular Oncology, directed by Dave Hoon. The research is designed to help develop new biomarker-specific blood tests for detecting cancer, the cancer institute said in a statement Tuesday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.